385 related articles for article (PubMed ID: 31229399)
41. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta-analysis and systematic review of randomized controlled trials.
Wu L; Liu Y; Huang X; Lin K; Liu Y; Li Z; Wei T; Song L; Hua Y; Wang X
Clin Endocrinol (Oxf); 2023 Jul; 99(1):3-16. PubMed ID: 36799083
[TBL] [Abstract][Full Text] [Related]
42. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
43. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
44. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Greff D; Juhász AE; Váncsa S; Váradi A; Sipos Z; Szinte J; Park S; Hegyi P; Nyirády P; Ács N; Várbíró S; Horváth EM
Reprod Biol Endocrinol; 2023 Jan; 21(1):10. PubMed ID: 36703143
[TBL] [Abstract][Full Text] [Related]
45. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
Wang A; Mo T; Li Q; Shen C; Liu M
Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
[TBL] [Abstract][Full Text] [Related]
46. Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Mar; 96(3):371-394. PubMed ID: 34713480
[TBL] [Abstract][Full Text] [Related]
47. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
[TBL] [Abstract][Full Text] [Related]
48. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
49. Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.
Monami M; Marchionni N; Mannucci E
Eur J Endocrinol; 2009 Jun; 160(6):909-17. PubMed ID: 19318378
[TBL] [Abstract][Full Text] [Related]
50. The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Ye ZR; Yan CQ; Liao N; Wen SH
Reprod Sci; 2023 Aug; 30(8):2349-2361. PubMed ID: 37002532
[TBL] [Abstract][Full Text] [Related]
51. Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis.
Palomba S; Pasquali R; Orio F; Nestler JE
Clin Endocrinol (Oxf); 2009 Feb; 70(2):311-21. PubMed ID: 18691273
[TBL] [Abstract][Full Text] [Related]
52. Short period-administration of myo-inositol and metformin on hormonal and glycolipid profiles in patients with polycystic ovary syndrome: a systematic review and updated meta-analysis of randomized controlled trials.
Zhang JQ; Xing C; He B
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):1792-1802. PubMed ID: 35363325
[TBL] [Abstract][Full Text] [Related]
53. The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Zhou Z; Chen H; Chu L; Zou Q; Chen Q; Yang J; Liu Y; Ou X
J Ovarian Res; 2023 Jun; 16(1):123. PubMed ID: 37381009
[TBL] [Abstract][Full Text] [Related]
54. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
[TBL] [Abstract][Full Text] [Related]
55. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
[TBL] [Abstract][Full Text] [Related]
56. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
[TBL] [Abstract][Full Text] [Related]
57. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
[TBL] [Abstract][Full Text] [Related]
58. Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis.
Chen LL; Zheng JH
Medicine (Baltimore); 2021 Jun; 100(24):e26289. PubMed ID: 34128863
[TBL] [Abstract][Full Text] [Related]
59. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
[TBL] [Abstract][Full Text] [Related]
60. A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J; Ren J; Sun W
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():13-21. PubMed ID: 27923166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
